Bluebird Bio Inc. sell StockNews.com
Start price
02.11.24
/
50%
€0.44
Target price
02.11.25
-
Performance (%)
-16.32%
End price
03.11.25
-
Summary
This prediction is currently being closed. The prediction for Bluebird Bio Inc. shows a convincing performance of -16.32%. StockNews_com has a follow-up prediction for Bluebird Bio Inc. where he still thinks Bluebird Bio Inc. is a Sell. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bluebird Bio Inc. | - | - | - |
| iShares Core DAX® | 2,49 % | -5,94 % | 2,90 % |
| iShares Nasdaq 100 | 1,65 % | -2,46 % | 15,75 % |
| iShares Nikkei 225® | 0,55 % | -7,60 % | 30,35 % |
| iShares S&P 500 | 1,35 % | -2,94 % | 10,34 % |
Comments by StockNews_com for this prediction
In the thread Bluebird Bio Inc. diskutieren
bluebird bio, Inc. (NASDAQ: BLUE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for BLUE provided by MarketBeat
In the thread Trading Bluebird Bio Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten